GLP-1s may offer a dual benefit for patients with chronic conditions like diabetes or obesity who are also struggling with a substance use disorder: one medication can treat both conditions at once, Al-Aly said
Long-Term Support: Can be used for daily maintenance and prevention
Medicare pricing $245/month (government price) $50/month copay for beneficiaries Eligibility: BMI 27 + metabolic risk factor (prediabetes, HTN, etc.) BMI 30 + CKD, HF, uncontrolled BP BMI 35 regardless of comorbidities Medicaid Will also receive reduced pricing Rollout depends on state decision timelines This expands coverage to millions of Americans
Below, we break down differences between Zepbound and Mounjaro, including how each medication is used, common side effects, dosages, and costs
Missing values were imputed by the predicted value from the MMRM model above, and continuous measurements were then dichotomized to binary outcomes